Press release
Driving End Stage Renal Disease (ESRD) Drug Market Growth in 2025: The Role of The Interconnection Of Obesity And Diabetes In Fueling End-Stage Renal Disease (ESRD) Drug Market Growth
End Stage Renal Disease (ESRD) Drug
End Stage Renal Disease (ESRD) Drug Market Size Growth Forecast: What to Expect by 2025?
The market size for drugs treating end stage renal disease (ESRD) has seen a quick expansion in the recent past. The market, which was valued at $131.41 billion in 2024, is forecasted to reach $149.88 billion in 2025, displaying a compound annual growth rate (CAGR) of 14.1%. Factors such as a surge in cases of end stage renal disease, a growing elderly population, better healthcare services availability, government steps and guidelines, alongside increased use of renal replacement therapies have contributed to this historic period growth.
How Will the End Stage Renal Disease (ESRD) Drug Market Size Evolve and Grow by 2029?
The market for end stage renal disease (ESRD) drug is projected to experience swift expansion in the coming years, escalating to a value of $268.44 billion in 2029 with a compound annual growth rate (CAGR) of 15.7%. The reasons for this growth in the forecast period include the emergence of innovative therapies and drugs, an increase in healthcare investment, the escalating global impact of chronic kidney diseases, the advent of personalized medicine strategies, supportive regulations, and expedited approval processes. The forecast period will also see trends such as increased cases of end stage renal disease, enhancements in treatment methods, a heightened focus on precision medicine, the formulation of combination therapies, and the incorporation of technology in healthcare.
View the full report here:
https://www.thebusinessresearchcompany.com/report/end-stage-renal-disease-esrd-drug-global-market-report
What Drivers Are Propelling the Growth of End Stage Renal Disease (ESRD) Drug Market Forward?
The increase in obesity and diabetes cases is predicted to fuel the end-stage renal disease (ESRD) drug market's expansion. Obesity is characterized by abnormal or excessive fat accumulation that poses a health risk, while diabetes is a long-term condition that occurs when the pancreas does not produce sufficient insulin or when the body is unable to effectively use the insulin that is produced. In individuals with renal disease, dialysis can be used to manage fluid and electrolyte levels, blood pressure, and the removal of waste products, which can enhance overall health and well-being, possibly leading to weight loss and better blood sugar management. For example, World Obesity, a US-based membership organization that represents national and regional associations devoted to studying and managing obesity, predicted in March 2022 that the global obese population will grow to 892 million by 2025 and then to 1,025 million by 2030. Moreover, according to the National Health Service, a publicly funded healthcare system based in the UK, it was estimated in February 2023 that by 2030, the number of people in the UK with diabetes might go up to 5.5 million, affecting close to 9% of the population. Thus, the escalating number of obesity and diabetes cases will stimulate the ESRD drug market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9437&type=smp
Which Emerging Trends Are Transforming the End Stage Renal Disease (ESRD) Drug Market in 2025?
Innovative product development is becoming a key trend for gaining traction in the end-stage renal disease (ESRD) drug market. It has been observed that top companies in the ESRD drug market are dedicating their efforts towards the creation of novel solutions to maintain their market presence. For example, in April 2022, the US Food and Drug Administration (FDA) acknowledged the New Drug Application (NDA) for daprodustat from GlaxoSmithKline PLC, which is a UK-based pharmaceutical and biotech company. This new drug, a form of oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), is intended for potential treatment of chronic kidney disease anemia (CKD). The product finds its foundation in the exclusive science realm that won a Nobel prize for discovering how cells recognize and respond to oxygen levels.
What Are the Key Segments in the End Stage Renal Disease (ESRD) Drug Market?
The end stage renal disease (ESRD) drug market covered in this report is segmented -
1) By Product Type: Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Other Products
2) By Indication: End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkaliemia
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Calcimimetics: Cinacalcet, Etelcalcetide
2) By Vitamin D: Calcitriol, Doxercalciferol, Paricalcitol
3) By Sterols: Ergocalciferol, Cholecalciferol
4) By Potassium Binders: Sodium Polystyrene Sulfonate, Patiromer, Sodium Zirconium Cyclosilicate
5) By Calcium-Based Phosphate Binders: Calcium Acetate, Calcium Carbonate
6) By Other Products: Iron Supplements, Erythropoiesis-Stimulating Agents
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9437&type=smp
Who Are the Key Players Shaping the End Stage Renal Disease (ESRD) Drug Market's Competitive Landscape?
Major companies operating in the end stage renal disease (ESRD) drug market include Pfizer Inc., AstraZeneca plc, Sanofi SA, Astellas Pharma Inc., Novartis AG, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd., Kissei Pharmaceutical Co. Ltd., Baxter International Inc., AbbVie Inc., Amgen Inc., Akebia Drugs Inc., Bayer AG, Bristol-Myers Squibb Company, B. Braun SE, Asahi Kasei Medical Co. Ltd., Nikkiso Co. Ltd., Abbott Laboratories, Merck Co. & KGaA
What Geographic Markets Are Powering Growth in the End Stage Renal Disease (ESRD) Drug Market?
North America was the largest region in the end stage renal disease (ESRD) drug market in 2024. The regions covered in the end stage renal disease (ESRD) drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9437
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Driving End Stage Renal Disease (ESRD) Drug Market Growth in 2025: The Role of The Interconnection Of Obesity And Diabetes In Fueling End-Stage Renal Disease (ESRD) Drug Market Growth here
News-ID: 4087988 • Views: …
More Releases from The Business Research Company
Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billio …
"Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Dermal Regeneration Market Size Forecast for 2025?
In recent years, the market size of dermal regeneration has significantly expanded. Its growth is set to continue, moving from a market value of $1.64 billion in 2024, surging to $1.79 billion in 2025, indicating a Compound Annual Growth Rate…
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Dental Emergency Kit Market from 2024 to 2025?
In recent times, the dental emergency kit market has seen significant growth. Projected growth rates suggest an increase from $1.18 billion in 2024 to $1.28 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.2%.…
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billio …
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Cryopreservation Equipment Market Size 2025?
The expansion of the cryopreservation equipment market has been significant in recent years. The market which is expected to escalate from $9.52 billion in 2024 to $11.01 billion in 2025, will do so with a compound annual growth rate…
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Connected Wearable Patches Market Grow by 2025 in Terms of Size and Growth?
The market size for connected wearable patches has seen significant expansion in the most recent years. With an expected rise from $5.62 billion in 2024 to $6.42 billion in 2025, representing a compound annual growth rate…
More Releases for ESRD
End Stage Renal Disease (ESRD) Drug Industry Report 2025-2034: Market Dynamics, …
The End Stage Renal Disease (ESRD) Drug Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current End Stage Renal Disease (ESRD) Drug Market Size and Its Estimated Growth Rate?
The market size for end-stage renal disease (ESRD) medications has witnessed a rapid upsurge…
End Stage Renal Disease (ESRD) Drug Market Report 2024 - End Stage Renal Disease …
"The Business Research Company recently released a comprehensive report on the Global End Stage Renal Disease (ESRD) Drug Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The…
End-Stage Renal Disease (ESRD) Market Share, Revenue, Prospects and Forecast 202 …
In recent years, the global End-Stage Renal Disease (ESRD) Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on End-Stage Renal Disease (ESRD) Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business…
End Stage Renal Disease (ESRD) Drug Market Size, Share, and Scope 2033
The new report published by The Business Research Company, titled ""End Stage Renal Disease (ESRD) Drug Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the end stage renal disease (esrd) drug market size has grown rapidly in recent years.…
End Stage Renal Disease (ESRD) Drug Market 2024-2033: Trends, Analysis & Growth …
The end stage renal disease (esrd) drug market size has grown rapidly in recent years. It will grow from $116.32 billion in 2023 to $132.86 billion in 2024 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to increasing incidence of end stage renal disease, growing aging population, improved access to healthcare services, government initiatives and policies, increasing adoption…
Dialysis Scheduling Software Market Insights by 2027 & Covid-19 Analysis | MIQS, …
This Dialysis Scheduling Software market report focuses on market share, size, competition level, key pricing structure and major key developments in the market. It further goes on with concentrating on financial requirements as well as investments. Some market strategies are discussed here for generating huge revenues through business. It further guides about how to track the business growth. New patented technologies and productions processes are also mentioned here to help…
